Christos Emmanouilides

Archive Network Publication Hotspot Collaboration

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Christos Emmanouilides is active.

Explore More

Publication

Featured researches published by Christos Emmanouilides.

Blood | 2004

Durable responses after ibritumomab tiuxetan radioimmunotherapy for CD20+ B-cell lymphoma: long-term follow-up of a phase 1/2 study.

Leo I. Gordon; Arturo Molina; Thomas E. Witzig; Christos Emmanouilides; Andrew Raubtischek; Mohamed Darif; Russell J. Schilder; Greg Wiseman; Christine A. White

Clinical Infectious Diseases | 1995

Infections in Liver Transplant Recipients

Drew J. Winston; Christos Emmanouilides; Ronald W. Busuttil

Clinical Infectious Diseases | 1994

Leptospirosis Complicated by a Jarisch-Herxheimer Reaction and Adult Respiratory Distress Syndrome: Case Report

Christos Emmanouilides; Orly F. Kohn; Richard A. Garibaldi

Blood | 2006

Analysis of the Incidence of Treatment-Related Myelodysplastic Syndrome and Acute Myelogenous Leukemia in Registration and Compassionate-Use Trials of Ibritumomab Tiuxetan Radioimmunotherapy (RIT).

Myron S. Czuczman; Christos Emmanouilides; Mohamed Darif; Thomas E. Witzig; Leo I. Gordon; Steven Revell; Katie Vo; Arturo Molina

Blood | 2007

Durable Complete Responses Following Therapy with Epratuzumab Plus Rituximab: Final Efficacy Results of a Multicenter Study in Recurrent Indolent Non-Hodgkin’s Lymphoma (NHL).

John P. Leonard; Stephen J. Schuster; Christos Emmanouilides; Felix Couture; Nick Teoh; William A. Wegener; David M. Goldenberg

Archive | 2013

CD20+ B-cell lymphoma: long-term follow-up of a phase 1/2 study Durable responses after ibritumomab tiuxetan radioimmunotherapy for

Mohamed Darif; Russell J. Schilder; Greg Wiseman; Christine A. White; Leo I. Gordon; Arturo Molina; Thomas E. Witzig; Christos Emmanouilides; Andrew Raubtischek

Archive | 2011

R a ndomized C ontrolled T rial o f Y ttrium-90 - Labeled Ibritumomab T iuxetan R adioimmunothera py V ersus Rituximab I mmunotherapy f or P atients W ith R elapsed o r Refractory L ow-Grade, F ollicular, o r T ransformed B -Cell Non-Hodgkin's L ymphoma

Thomas E. Witzig; Leo I. Gordon; Fernando Cabanillas; Myron S. Czuczman; Christos Emmanouilides; Robin Joyce; Brad Pohlman; Nancy L. Bartlett; Gregory A. Wiseman; Norman Padre; Pratik S. Multani; Christine A. White

Archive | 2004

Durable Responses after Ibritumomab Tiuxetan Radioimmunotherapy for CD20 + B -Cell Lymphoma: Long Term Follow -up of a

Leo I. Gordon; Arturo Molina; Thomas E. Witzig; Christos Emmanouilides; Andrew Raubtische; Mohamed Darif; Russell J. Schilder; Gregory A. Wiseman; Christine A. White; Robert H. Lurie

Blood | 2004